Nutritional Therapy in Patients With Post-extubation Dysphagia
ConditionDysphagia
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorNational Institute of Respiratory Diseases, Mexico
About this trial
The aim of this study is to evaluate the impact of the prescription of two doses of protein on the amount in kilograms of muscle mass and on the clinical evolution (time until safe swallowing, time until removal of the feeding stoma, number of hospital readmissions, feeding stoma infections, incidence of pneumonia, functionality, number of falls, fractures and mortality) at 6 months after hospital discharge in patients with enteral nutrition due to post-extubation dysphagia.
Eligibility criteria
Qualifiers
Patients who required invasive mechanical ventilation during their hospital stay with a diagnosis of post-extubation dysphagia diagnosed by fibroendoscopy evaluation of swallowing (FEES).
Patients who discharged with a feeding tube.
Patients with signed informed consent.
Disqualifiers
Patients with pre-existing dysphagia, or with neurological conditions that can cause dysphagia (e.g. multiple sclerosis, Parkinson's disease, Alzheimer's, myasthenia gravis).
Patients with chronic kidney disease, defined as a glomerular filtration rate <60 ml/min.
Patients discharged with a terminal condition and/or life expectancy of less than 3 months.
Diagnosis of HIV, upon receiving clinical follow-up by the team of specialists.
Trial design
Treatments tested in this trial
- High protein dose
- Usual protein dose
Treatment groups
128 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov